Article

AI Model for Predicting Anti-PD1 Response in Melanoma Using Multi-Omics Biomarkers

2025-01-13

Abstract excerpt

<h4>Background: </h4> Immune checkpoint inhibitors (ICIs) have demonstrated significantly improved clinical efficacy in a minority of patients with advanced melanoma, whereas non-responders potentially suffer from severe side effects and delays in other treatment options. Predicting the response to anti-PD1 treatment in melanoma remains a challenge because the current FDA-approved gold standard, the nonsynonymous...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 133fd986-fde6-5c4a-89b5-bcb8db9b7e77
DOI: 10.20944/preprints202501.0904.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

AI Model for Predicting Anti-PD1 Response in Melanoma Using Multi-Omics BiomarkersDOI 10.20944/preprints202501.0904.v1Read

Integrative Multi-Omics Analysis of Melanoma: Uncovering Pathways Associated with Immunotherapy OutcomesSemantic proximity Read

Explainable machine learning identifies features and thresholds predictive of immunotherapy responseSemantic proximity Read

Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysisSemantic proximity Read

Transcriptional analysis of immune modulatory genes in melanoma treated with PD-1 blockadeSemantic proximity Read

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.Semantic proximity Read

Multi-omics Profiling of Patients with Melanoma Treated with Nivolumab in Project HOPE.Semantic proximity Read

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy ResponseSemantic proximity Read

The melanoma MEGA-study: Integrating proteogenomics, digital pathology, and AI-analytics for precision oncologySemantic proximity Read

The combination of single-cell and bulk RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genesSemantic proximity Read

Construction of immune scores to predict patient prognosis and response of anti-PD1 treatment in stage III-IV melanomaSemantic proximity Read

IOBR: Multi-omics Immuno-Oncology Biological Research to decode tumor microenvironment and signaturesSemantic proximity Read

Integrative single-cell profiling of melanoma reveals a tumor microenvironment signature predictive of immunotherapy responseSemantic proximity Read